להשאר עם טמוקסי - ממליצים הרופאים
A panel of oncologists yesterday urged doctors to stick to the time-tested drug tamoxifen in the treatment of breast cancer despite evidence that newer drugs may do a better job of preventing recurrence. Studies on a new generation of drugs called aromatase inhibitors have initially shown them to be slightly more effective at preventing a relapse than tamoxifen. Their emergence last December was initially hailed as a breakthrough. כתובת המאמר:http://www.guardian.co.uk/uk_news/story/0,3604,718785,00.html
A panel of oncologists yesterday urged doctors to stick to the time-tested drug tamoxifen in the treatment of breast cancer despite evidence that newer drugs may do a better job of preventing recurrence. Studies on a new generation of drugs called aromatase inhibitors have initially shown them to be slightly more effective at preventing a relapse than tamoxifen. Their emergence last December was initially hailed as a breakthrough. כתובת המאמר:http://www.guardian.co.uk/uk_news/story/0,3604,718785,00.html
